CEACAM21
Cell adhesion molecule CEACAM21
Also known as: CEA21_HUMAN, FLJ13540, R29124_1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3KPI0
- Gene
- CEACAM21
- Ensembl
- ENSG00000007129
- Chromosome
- 19
- Canonical length
- 293 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Predicted to be involved in T cell activation and immune response. Predicted to be located in membrane. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
293 residues, UniProt reviewed canonical sequence.
>Q3KPI0|CEACAM21
1 MGPPSACPHR ECIPWQGLLL TASLLTFWNA PTTAWLFIAS APFEVAEGEN VHLSVVYLPE
61 NLYSYGWYKG KTVEPNQLIA AYVIDTHVRT PGPAYSGRET ISPSGDLHFQ NVTLEDTGYY
121 NLQVTYRNSQ IEQASHHLRV YESVAQPSIQ ASSTTVTEKG SVVLTCHTNN TGTSFQWIFN
181 NQRLQVTKRM KLSWFNHVLT IDPIRQEDAG EYQCEVSNPV SSNRSDPLKL TVKSDDNTLG
241 ILIGVLVGSL LVAALVCFLL LRKTGRASDQ SDFREQQPPA STPGHGPSDS SISLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CEACAM21 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 17 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 17 nTPM
- spleen: 9.9 nTPM
- lymph node: 5 nTPM
- midbrain: 4.6 nTPM
- hypothalamus: 4 nTPM
- lung: 3.7 nTPM
Single-cell type
- microglia: 36 nCPM
- megakaryocytes: 12 nCPM
- nk-cells: 6.7 nCPM
- hepatic stellate cells: 6.5 nCPM
- other brain neurons: 5.3 nCPM
- t-cells: 5.1 nCPM
Immune cell
- neutrophil: 30 nTPM
- gdT-cell: 30 nTPM
- eosinophil: 27 nTPM
- T-reg: 27 nTPM
- memory CD4 T-cell: 26 nTPM
- naive CD4 T-cell: 21 nTPM
Brain region
- hypothalamus: 7.3 nTPM
- midbrain: 5.1 nTPM
- pons: 3.8 nTPM
- medulla oblongata: 3.2 nTPM
- spinal cord: 2.7 nTPM
- thalamus: 2.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.7
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.32
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CEACAM21 as an antibody target. Whether an autoantibody or antibody against CEACAM21 could matter depends on whether native CEACAM21 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CEACAM21 is annotated at the cell surface, where native CEACAM21 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CEACAM21 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...